Joseph Beaulieu - Net Worth and Insider Trading

Joseph Beaulieu Net Worth

The estimated net worth of Joseph Beaulieu is at least $42,089 dollars as of 2024-12-28. Joseph Beaulieu is the Corporate Controller of Epizyme Inc and owns about 28,632 shares of Epizyme Inc (EPZM) stock worth over $42,089. Details can be seen in Joseph Beaulieu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Beaulieu has not made any transactions after 2022-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joseph Beaulieu

To

Joseph Beaulieu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Beaulieu owns 1 companies in total, including Epizyme Inc (EPZM) .

Click here to see the complete history of Joseph Beaulieu’s form 4 insider trades.

Insider Ownership Summary of Joseph Beaulieu

Ticker Comapny Transaction Date Type of Owner
EPZM Epizyme Inc 2022-02-07 Corporate Controller

Joseph Beaulieu Latest Holdings Summary

Joseph Beaulieu currently owns a total of 1 stock. Joseph Beaulieu owns 28,632 shares of Epizyme Inc (EPZM) as of February 7, 2022, with a value of $42,089.

Latest Holdings of Joseph Beaulieu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EPZM Epizyme Inc 2022-02-07 28,632 1.47 42,089

Holding Weightings of Joseph Beaulieu


Joseph Beaulieu Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Beaulieu has made a total of 8 transactions in Epizyme Inc (EPZM) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Epizyme Inc is the sale of 222 shares on February 7, 2022, which brought Joseph Beaulieu around $333.

Insider Trading History of Joseph Beaulieu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Beaulieu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Beaulieu Ownership Network

Ownership Network List of Joseph Beaulieu

No Data

Ownership Network Relation of Joseph Beaulieu

Insider Network Chart

Joseph Beaulieu Owned Company Details

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Joseph Beaulieu is the Corporate Controller of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Chief Medical Officer Shefali Agarwal .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Epizyme Inc Insider Transactions

No Available Data

Joseph Beaulieu Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Beaulieu. You might contact Joseph Beaulieu via mailing address: C/o Epizyme, Inc. 400 Technology Square Cambridge Ma 02139.

Discussions on Joseph Beaulieu

No discussions yet.